litlas
Log inCreate account

Fazlul H. Sarkar

Active 1992–2017

Also published as
Fazlul, H. Sarkar
215
Papers
37,639
Citations
119
h-index
215
i10-index

Citations

Citations per year for Fazlul H. Sarkar1983: 1 citations1986: 1 citations1994: 2 citations1995: 2 citations1996: 11 citations1997: 5 citations1998: 11 citations1999: 15 citations2000: 17 citations2001: 52 citations2002: 70 citations2003: 92 citations2004: 189 citations2005: 225 citations2006: 204 citations2007: 303 citations2008: 335 citations2009: 414 citations2010: 613 citations2011: 705 citations2012: 768 citations2013: 755 citations2014: 689 citations2015: 652 citations2016: 532 citations2017: 496 citations2018: 372 citations2019: 1,192 citations2020: 1,170 citations2021: 1,089 citations2022: 791 citations2023: 557 citations2024: 673 citations2025: 269 citations2026: 6 citations1984–1985: no citations, so these years are not shown1987–1993: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,245 citing papers, 23.7% of this breakdownChina: 2,313 citing papers, 16.9% of this breakdownIndia: 946 citing papers, 6.9% of this breakdownItaly: 512 citing papers, 3.8% of this breakdownGermany: 441 citing papers, 3.2% of this breakdownUnited Kingdom: 437 citing papers, 3.2% of this breakdownIran: 420 citing papers, 3.1% of this breakdownSouth Korea: 393 citing papers, 2.9% of this breakdownJapan: 370 citing papers, 2.7% of this breakdownSaudi Arabia: 316 citing papers, 2.3% of this breakdownAustralia: 305 citing papers, 2.2% of this breakdownSpain: 255 citing papers, 1.9% of this breakdown
0%23.7%Other 27.2%

Institutions

Fields

  • Biochemistry, Genetics and Molecular Biology48%
  • Medicine37.5%
  • Nursing2.4%
  • Pharmacology, Toxicology and Pharmaceutics2.3%
  • Materials Science2.1%
  • Immunology and Microbiology1.7%
  • Other6%

Topics

  • MicroRNA in disease regulation5.4%
  • Cancer Cells and Metastasis3.9%
  • Cancer-related molecular mechanisms research2.7%
  • Circular RNAs in diseases2.5%
  • Extracellular vesicles in disease2.4%
  • Pancreatic and Hepatic Oncology Research2.2%
  • Other80.9%

Coauthors

All papers

Open in search
  1. Exosomes in cancer development, metastasis, and drug resistance: a comprehensive review

    Authors: Asfar S. Azmi, Bin Bao, Fazlul H. Sarkar - Cancer and Metastasis Reviews 2013 cited by 1,224

  2. The Role of Notch Signaling Pathway in Epithelial-Mesenchymal Transition (EMT) During Development and Tumor Aggressiveness

    Authors: Zhiwei Wang, Yiwei Li, Dejuan Kong, Fazlul H. Sarkar - Current Drug Targets 2010 cited by 336

  3. PAMAM dendrimers as promising nanocarriers for RNAi therapeutics

    Authors: Prashant Kesharwani, Sanjeev Banerjee, Umesh Gupta, Mohd Cairul Iqbal Mohd Amin, Subhash Padhyé, Fazlul H. Sarkar, Arun K. Iyer - Materials Today 2015 cited by 283

  4. Multi-targeted therapy of cancer by genistein

    Authors: Sanjeev Banerjee, Yiwei Li, Zhiwei Wang, Fazlul H. Sarkar - Cancer Letters 2008 cited by 619

  5. Overview of Cancer Stem Cells (CSCs) and Mechanisms of Their Regulation: Implications for Cancer Therapy

    Authors: Bin Bao, Aamir Ahmad, Asfar S. Azmi, Shadan Ali, Fazlul H. Sarkar - Current Protocols in Pharmacology 2013 cited by 287

  6. Acquisition of Epithelial-Mesenchymal Transition Phenotype of Gemcitabine-Resistant Pancreatic Cancer Cells Is Linked with Activation of the Notch Signaling Pathway

    Authors: Zhiwei Wang, Yiwei Li, Dejuan Kong, Sanjeev Banerjee, Aamir Ahmad, Asfar S. Azmi, Shadan Ali, James L. Abbruzzese, Gary E. Gallick, Fazlul H. Sarkar - Cancer Research 2009 cited by 622

  7. Pancreatic cancer: understanding and overcoming chemoresistance

    Authors: Zhiwei Wang, Yiwei Li, Aamir Ahmad, Sanjeev Banerjee, Asfar S. Azmi, Dejuan Kong, Fazlul H. Sarkar - Nature Reviews Gastroenterology & Hepatology 2010 cited by 385

  8. Antioxidant effect of zinc in humans

    Authors: Ananda S. Prasad, Bin Bao, Frances W.J. Beck, Omer Kucuk, Fazlul H. Sarkar - Free Radical Biology and Medicine 2004 cited by 518

  9. Hyaluronic acid-conjugated polyamidoamine dendrimers for targeted delivery of 3,4-difluorobenzylidene curcumin to CD44 overexpressing pancreatic cancer cells

    Authors: Prashant Kesharwani, Lingxiao Xie, Sanjeev Banerjee, Guangzhao Mao, Subhash Padhyé, Fazlul H. Sarkar, Arun K. Iyer - Colloids and Surfaces B Biointerfaces 2015 cited by 209

  10. Targeted Regulation of PI3K/Akt/mTOR/NF-κB Signaling by Indole Compounds and their Derivatives: Mechanistic Details and Biological Implications for Cancer Therapy

    Authors: Aamir Ahmad, Bernhard Biersack, Yiwei Li, Dejuan Kong, Bin Bao, Rainer Schobert, Subhash Padhyé, Fazlul H. Sarkar - Anti-Cancer Agents in Medicinal Chemistry 2013 cited by 197

  11. Up-regulation of miR-200 and let-7 by Natural Agents Leads to the Reversal of Epithelial-to-Mesenchymal Transition in Gemcitabine-Resistant Pancreatic Cancer Cells

    Authors: Yiwei Li, Timothy VandenBoom, Dejuan Kong, Zhiwei Wang, Shadan Ali, Philip A. Philip, Fazlul H. Sarkar - Cancer Research 2009 cited by 658

  12. Perspectives on medicinal properties of plumbagin and its analogs

    Authors: Subhash Padhyé, Prasad Dandawate, Yusufi Mujahid, Aamir Ahmad, Fazlul H. Sarkar - Medicinal Research Reviews 2010 cited by 315

  13. Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs

    Authors: Subhash Padhyé, Aamir Ahmad, Nikhil Oswal, Fazlul H. Sarkar - Journal of Hematology & Oncology 2009 cited by 239

  14. Metformin Inhibits Cell Proliferation, Migration and Invasion by Attenuating CSC Function Mediated by Deregulating miRNAs in Pancreatic Cancer Cells

    Authors: Bin Bao, Zhiwei Wang, Shadan Ali, Aamir Ahmad, Asfar S. Azmi, Sanila H. Sarkar, Sanjeev Banerjee, Dejuan Kong, Yiwei Li, Shivam Thakur, Fazlul H. Sarkar - Cancer Prevention Research 2011 cited by 335

  15. Targeting Notch signaling pathway to overcome drug resistance for cancer therapy

    Authors: Zhiwei Wang, Yiwei Li, Aamir Ahmad, Asfar S. Azmi, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2010 cited by 234

  16. Curcumin Synergizes With Resveratrol to Inhibit Colon Cancer

    Authors: Adhip P.N. Majumdar, Sanjeev Banerjee, Jyoti Nautiyal, Bhaumik B. Patel, Vaishali Patel, Jianhua Du, Yingjie Yu, Althea A. Elliott, Edi Levi, Fazlul H. Sarkar - Nutrition and Cancer 2009 cited by 197

  17. The biological kinship of hypoxia with CSC and EMT and their relationship with deregulated expression of miRNAs and tumor aggressiveness

    Authors: Bin Bao, Asfar S. Azmi, Shadan Ali, Aamir Ahmad, Yiwei Li, Sanjeev Banerjee, Dejuan Kong, Fazlul H. Sarkar - Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2012 cited by 180

  18. Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance

    Authors: Zhiwei Wang, Yiwei Li, Aamir Ahmad, Asfar S. Azmi, Dejuan Kong, Sanjeev Banerjee, Fazlul H. Sarkar - Drug Resistance Updates 2010 cited by 352

  19. Emerging role of Notch in stem cells and cancer

    Authors: Zhiwei Wang, Yiwei Li, Sanjeev Banerjee, Fazlul H. Sarkar - Cancer Letters 2008 cited by 274

  20. Inactivation of NF-κB by genistein is mediated via Akt signaling pathway in breast cancer cells

    Authors: Lijie Gong, Yiwei Li, Ana Nedeljkovic-Kurepa, Fazlul H. Sarkar - Oncogene 2003 cited by 237

  21. Tumour vasculogenic mimicry is associated with poor prognosis of human cancer patients: A systemic review and meta-analysis

    Authors: Zhifei Cao, Meimei Bao, Lucio Miele, Fazlul H. Sarkar, Zhiwei Wang, Quansheng Zhou - European Journal of Cancer 2013 cited by 231

  22. Implication of microRNAs in drug resistance for designing novel cancer therapy

    Authors: Fazlul H. Sarkar, Yiwei Li, Zhiwei Wang, Dejuan Kong, Shadan Ali - Drug Resistance Updates 2010 cited by 211

  23. Clioquinol, a Therapeutic Agent for Alzheimer's Disease, Has Proteasome-Inhibitory, Androgen Receptor–Suppressing, Apoptosis-Inducing, and Antitumor Activities in Human Prostate Cancer Cells and Xenografts

    Authors: Di Chen, Qiuzhi Cindy Cui, Huanjie Yang, Raúl A. Barrea, Fazlul H. Sarkar, Shijie Sheng, Bing Yan, G. Prem Veer Reddy, Q. Ping Dou - Cancer Research 2007 cited by 211

  24. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells

    Authors: Prashant Kesharwani, Sanjeev Banerjee, Subhash Padhyé, Fazlul H. Sarkar, Arun K. Iyer - Biomacromolecules 2015 cited by 148